MedMen Scraps Its PharmaCann Acquisition: Disaster or No Big Deal?
The company also replaced its CFO in conjunction with the news.
MedMen Enterprises Inc.
MMNFF
MMNFF
$1.17
-$0.02
-1.7%
BATS BZX Real Time Price as of October 14, 2019, 3:58 p.m. EDT
View Interactive MMNFF Charts
News & Analysis: MedMen Enterprises Inc.
The Fool has written over 100 articles on MedMen Enterprises Inc..
Wow! This Marijuana Megamerger Just Imploded.
What was once the largest announced acquisition in U.S. cannabis history is no more.
Cannabis Stocks MedMen Enterprises and PharmaCann Scrap $682 Million Merger
Changing industry dynamics are forcing these marijuana companies to scuttle a once-promising combination.
3 Cannabis Stocks That May Not Be Profitable Until 2022
Don't expect these brand-name pot stocks to deliver the green anytime soon.
Marijuana Value Traps Do Exist: Here Are 3 to Avoid
Two of these three pot stocks are trading below their book value, but that doesn't make them worth buying.
3 Pot Stocks to Avoid Like the Plague in the Fourth Quarter
A few popular cannabis stocks aren't the bargains they're made out to be.
Will These U.S. Cannabis Megadeals Ever Be Completed?
A number of marijuana acquisitions are taking longer than expected to close.
3 Pot Stocks I Wouldn't Buy With Free Money
Brand-name marijuana stocks don't always make for the best investments.
Better Marijuana Stock: MedMen vs. Village Farms
Which stock wins in a matchup between a leading U.S. cannabis retailer and an up-and-coming Canadian cannabis producer?
Buy These 3 Marijuana Stocks, According to Wall Street
One investment bank sees 41% to 96% upside in three popular pot stocks.
